Search Images Maps Play YouTube News Gmail Drive More »
Sign in
Screen reader users: click this link for accessible mode. Accessible mode has the same essential features but works better with your reader.

Patents

  1. Advanced Patent Search
Publication numberUS20060206200 A1
Publication typeApplication
Application numberUS 11/420,025
Publication dateSep 14, 2006
Filing dateMay 24, 2006
Priority dateMay 25, 2004
Also published asCA2652022A1, CA2652022C, CN101472536A, CN101472536B, CN103169522A, EP2026716A2, EP2026716A4, US8382825, US20110166592, US20140074149, WO2007139699A2, WO2007139699A3
Publication number11420025, 420025, US 2006/0206200 A1, US 2006/206200 A1, US 20060206200 A1, US 20060206200A1, US 2006206200 A1, US 2006206200A1, US-A1-20060206200, US-A1-2006206200, US2006/0206200A1, US2006/206200A1, US20060206200 A1, US20060206200A1, US2006206200 A1, US2006206200A1
InventorsAdrian Garcia, Ting Ye, Quang Tran, Aaron Berez
Original AssigneeChestnut Medical Technologies, Inc.
Export CitationBiBTeX, EndNote, RefMan
External Links: USPTO, USPTO Assignment, Espacenet
Flexible vascular occluding device
US 20060206200 A1
Abstract
A vascular occluding device for modifying blood flow in a vessel, while maintaining blood flow to the surrounding tissue. The occluding device includes a flexible, easily compressible and bendable occluding device that is particularly suited for treating aneurysms in the brain. The neurovascular occluding device can be deployed using a micro-catheter. The occluding device can be formed by braiding wires in a helical fashion and can have varying lattice densities along the length of the occluding device. The occluding device could also have different lattice densities for surfaces on the same radial plane.
Images(30)
Previous page
Next page
Claims(19)
1. A tubular-shaped device for positioning within a blood vessel for embolization of an aneurysm, the device including a plurality of strands of helically-wound material in a lattice structure forming a plurality of braiding elements, wherein a width of a braiding element is based on the number of strands of helically-wound material.
2. The device of claim 1 wherein the width of the braiding element is proportional to a constant.
3. The device of claim 2 wherein the constant is equal to π.
4. The device of claim 1, wherein the width of the braiding element is about equal to [(π)*(a diameter of a forming device)]/(number of strands of helically-wound material/2).
5. The device of claim 1, wherein the braiding elements contain at least two sides forming a ribbon angle, the ribbon angle based on the width of the braiding element.
6. The device of claim 5 wherein the ribbon angle is selectively configured based on a predetermined width of the braiding element.
7. The device of claim 5 wherein the ribbon angle is further configured for fitting the device in a vessel of a predetermined diameter.
8. The device of claim 7 wherein a size of the ribbon angle is directly proportional to a size of the width of the braiding element.
9. The device of claim 1 further including a protective coil encompassing the device.
10. The device of claim 9 wherein the number of strands of helically wound material is based on the protective coil encompassing the device.
11. The device of claim 10 wherein the number of strands of helically wound material is about equal to or less than (720 degrees)/(Arc-angle), wherein the arc-angle is defined by an angle at a center point of the protective coil formed by the width of the braiding element at a peripheral surface of the protective coil.
12. A method for manufacturing a device in a circular coil for positioning within a blood vessel for embolization of an aneurysm, the device including a plurality of interlacing ribbons, the method comprising the steps of:
positioning a ribbon in the coil;
providing a plurality of ribbons for the device based on a calculated arc-angle of said positioned ribbon;
interlacing said ribbons to form the device.
13. The method of claim 12 wherein the step of positioning the ribbon in the coil comprises:
placing a first ribbon in contact with an inner surface of the coil;
determining an inner circumference tangent to a bottom surface of the first ribbon; positioning a second ribbon in contact with the inner circumference,
wherein the step of calculating the arc-angle is based on the second ribbon.
14. The method of claim 13 wherein the arc-angle is defined by an angle at a center point of the protective coil formed by the width of the second ribbon.
15. The method of claim 12 wherein the plurality of ribbons is greater than or equal to 8.
16. The method of claim 15 wherein the plurality of ribbons is greater than or equal to 32.
17. The method of claim 16 wherein the plurality of ribbons is 48.
18. The method of claim 16 wherein the plurality of ribbons is 60.
19. The method of claim 16 wherein the plurality of ribbons is greater than 60.
Description
    RELATED APPLICATION
  • [0001]
    This application is a Continuation-in-part of and claims priority to U.S. application Ser. No. 11/136,395, filed May 25, 2005, which claims the benefit of U.S. Provisional Application Ser. No. 60/574,429, entitled “Flexible Vascular Prosthesis,” filed May 25, 2004. Each of these applications is expressly incorporated herein by reference in their entireties.
  • FIELD OF THE INVENTION
  • [0002]
    The invention relates generally to an implantable device that could be used in the vasculature to treat common vascular malformations. More particularly, it relates to a flexible, biocompatible device that can be introduced into the vasculature of a patient to embolize and occlude aneurysms, particularly cerebral aneurysms.
  • BACKGROUND OF THE INVENTION
  • [0003]
    Walls of the vasculature, particularly arterial walls, may develop pathological dilatation called an aneurysm. Aneurysms are commonly observed as a ballooning-out of the wall of an artery. This is a result of the vessel wall being weakened by disease, injury or a congenital abnormality. Aneurysms have thin, weak walls and have a tendency to rupture and are often caused or made worse by high blood pressure. Aneurysms could be found in different parts of the body; the most common being abdominal aortic aneurysms (AAA) and the brain or cerebral aneurysms. The mere presence of an aneurysm is not always life-threatening, but they can have serious heath consequences such as a stroke if one should rupture in the brain. Additionally, as is known, a ruptured aneurysm can also result in death.
  • [0004]
    The most common type of cerebral aneurysm is called a saccular aneurysm, which is commonly found at the bifurcation of a vessel. The locus of bifurcation, the bottom of the V in the Y, could be weakened by hemodynamic forces of the blood flow. On a histological level, aneurysms are caused by damage to cells in the arterial wall. Damage is believed to be caused by shear stresses due to blood flow. Shear stress generates heat that breaks down the cells. Such hemodynamic stresses at the vessel wall, possibly in conjunction with intrinsic abnormalities of the vessel wall, have been considered to be the underlying cause for the origin, growth and rupture of these saccular aneurysms of the cerebral arteries (Lieber and Gounis, The Physics of Endoluminal stenting in the Treatment of Cerebrovascular Aneurysms, Neurol Res 2002: 24: S32-S42). In histological studies, damaged intimal cells are elongated compared to round healthy cells. Shear stress can vary greatly at different phases of the cardiac cycle, locations in the arterial wall and among different individuals as a function of geometry of the artery and the viscosity, density and velocity of the blood. Once an aneurysm is formed, fluctuations in blood flow within the aneurysm are of critical importance because they can induce vibrations of the aneurysm wall that contribute to progression and eventual rupture. For a more detailed description of the above concepts see, for example, Steiger, Pathophysiology of Development and Rupture of Cerebral Aneurysms, Acta Neurochir Suppl 1990: 48: 1-57; Fergueson, Physical Factors in the Initiation, Growth and Rupture of Human Intracranial Saccular Aneurysms, J Neurosurg 1972: 37: 666-677.
  • [0005]
    Aneurysms are generally treated by excluding the weakened part of the vessel from the arterial circulation. For treating a cerebral aneurysm, such reinforcement is done in many ways: (i) surgical clipping, where a metal clip is secured around the base of the aneurysm; (ii) packing the aneurysm with microcoils, which are small, flexible wire coils; (iii) using embolic materials to “fill” an aneurysm; (iv) using detachable balloons or coils to occlude the parent vessel that supplies the aneurysm; and (v) endovascular stenting. For a general discussion and review of these different methods see Qureshi, Endovascular Treatment of Cerebrovascular Diseases and Intracranial Neoplasms, Lancet. 2004 Mar. 6;363 (9411):804-13; Brilstra et al. Treatment of Intracranial Aneurysms by Embolization with Coils: A Systematic Review, Stroke 1999; 30: 470-476.
  • [0006]
    As minimally invasive interventional techniques gain more prominence, micro-catheter based approaches for treating neurovascular aneurysms are becoming more prevalent. Micro-catheters, whether flow-directed or wire-directed, are used for dispensing embolic materials, microcoils or other structures (e.g., stents) for embolization of the aneurysm. A microcoil can be passed through a micro-catheter and deployed in an aneurysm using mechanical or chemical detachment mechanisms, or be deployed into the parent vessel to permanently occlude it and thus block flow into the aneurysm. Alternatively, a stent could be tracked through the neurovasculature to the desired location. Article by Pereira, History of Endovascular Aneurysms Occlusion in Management of Cerebral Aneurysms; Eds: Le Roux et al., 2004, pp: 11-26 provides an excellent background on the history of aneurysm detection and treatment alternatives.
  • [0007]
    As noted in many of the articles mentioned above, and based on the origin, formation and rupture of the cerebral aneurysm, it is obvious that the goal of aneurysmal therapy is to reduce the risk of rupture of the aneurysm and thus the consequences of sub-arachnoid hemorrhage. It should also be noted that while preventing blood from flowing into the aneurysm is highly desirable, so that the weakened wall of the aneurysm doesn't rupture, it may also be vital that blood flow to the surrounding structures is not limited by the method used to obstruct blood flow to the aneurysm. Conventional stents developed for treating other vascular abnormalities in the body are ill suited for embolizing cerebral aneurysms. This could lead to all the usual complications when high oxygen consumers, such as brain tissue, are deprived of the needed blood flow.
  • [0008]
    There are many shortcomings with the existing approaches for treating neurovascular aneurysms. The vessels of the neurovasculature are the most tortuous in the body; certainly more tortuous than the vessels of the coronary circulation. Hence, it is a challenge for the surgeon to navigate the neurovasculature using stiff coronary stents that are sometimes used in the neurovasculature for treating aneurysms. The bending force of a prosthesis indicates the maneuverability of the prosthesis through the vasculature; a lower bending force would imply that the prosthesis is more easily navigated through the vasculature compared to one with a higher bending force. Bending force for a typical coronary stent is 0.05 lb-in (force to bend 0.5 inches cantilever to 90 degree). Hence, it will be useful to have neural prosthesis that is more flexible than existing stents.
  • [0009]
    Existing stent structures, whether used in coronary vessels or in the neurovasculature (microcoils) are usually straight, often laser cut from a straight tubing or braiding with stiff metallic materials. However, most of the blood vessels are curved. Hence, current stent structures and microcoils impart significant stress on the vessel walls as they try to straighten a curved vessel wall. For a weakened vessel wall, particularly where there is a propensity for an aneurysm formation, this could have disastrous consequences.
  • [0010]
    As noted earlier, the hemodynamic stress placed on the blood vessels, particularly at the point of bifurcation, leads to weakening of the vessel walls. The most significant source of such stress is the sudden change in direction of the blood flow. Hence, if one were to minimize the sudden change in direction of blood flow, particularly at the location of vessel weakness, it would be beneficial.
  • [0011]
    Existing approaches to occluding aneurysms could lead to another set of problems. Methods that merely occlude the aneurysm by packing or filling it with embolic material (coils or liquid polymers) do not address the fundamental flow abnormalities that contribute to the formation of aneurysm.
  • [0012]
    A stent structure could be expanded after being placed intraluminally on a balloon catheter. Alternatively, self-expanding stems could be inserted in a compressed state and expanded upon deployment. For balloon expandable stents, the stent is mounted on a balloon at the distal end of a catheter, the catheter is advanced to the desired location and the balloon is inflated to expand the stent into a permanent expanded condition. The balloon is then deflated and the catheter withdrawn leaving the expanded stent to maintain vessel patency. Because of the potentially lethal consequences of dissecting or rupturing an intracerebral vessel, the use of balloon expandable stents in the brain is fraught with problems. Proper deployment of a balloon expandable stent requires slight over expanding of the balloon mounted stent to embed the stent in the vessel wall and the margin of error is small. Balloon expandable stents are also poorly suited to adapt to the natural tapering of cerebral vessels which taper proximally to distally. If a stent is placed from a parent vessel into a smaller branch vessel the change in diameter between the vessels makes it difficult to safely deploy a balloon expandable stent. A self-expanding stent, where the compressed or collapsed stent is held by an outer restraining sheath over the compressed stent to maintain the compressed state until deployment. At the time of deployment, the restraining outer sheath is retracted to uncover the compressed stent, which then expands to keep the vessel open. Additionally, the catheters employed for delivering such prosthesis are micro-catheters with outer diameter of 0.65 mm to 1.3 mm compared to the larger catheters that are used for delivering the large coronary stents to the coronaries.
  • [0013]
    U.S. Pat. No. 6,669,719 (Wallace et al.) describes a stent and a stent catheter for intra-cranial use. A rolled sheet stent is releasably mounted on the distal tip of a catheter. Upon the rolled sheet being positioned at the aneurysm, the stent is released. This results in immediate and complete isolation of an aneurysm and surrounding side branches of the circulatory system and redirecting blood flow away from the aneurysm. A significant drawback of such a system is that the surrounding side branches, along with the target aneurysm, are deprived of the needed blood flow after the stent has been deployed.
  • [0014]
    U.S. Pat. No. 6,605,110 (Harrison) describes a self-expanding stent for delivery through a tortuous anatomy or for conforming the stent to a curved vessel. This patent describes a stent structure with radially expandable cylindrical elements arranged in parallel to each other and interspersed between these elements and connecting two adjacent cylindrical elements are struts that are bendable. While this structure could provide the necessary flexibility and bendability of the stent for certain applications, it is expensive and complex to manufacture.
  • [0015]
    U.S. Pat. No. 6,572,646 (Boylan) discloses a stent made up of a super-elastic alloy, such as Ni—Ti alloy (Nitinol), with a low temperature phase that induces a first shape to the stent and a high temperature phase that induces a second shape to the stent with a bend along the length. U.S. Pat. No. 6,689,162 (Thompson) discloses a braided prosthesis that uses strands of metal, for providing strength, and compliant textile strands. U.S. Pat. No. 6,656,218 (Denardo et al.) describes an intravascular flow modifier that allows microcoil introduction.
  • SUMMARY OF THE INVENTION
  • [0016]
    An aspect of the present invention provides a highly flexible implantable occluding device that can easily navigate the tortuous vessels of the neurovasculature. Additionally, occluding device can easily conform to the shape of the tortuous vessels of the vasculature. Furthermore, the occluding device can direct the blood flow within a vessel away from an aneurysm; additionally such an occluding device allows adequate blood flow to be provided to adjacent structures such that those structures, whether they are branch vessels or oxygen demanding tissues, are not deprived of the necessary blood flow.
  • [0017]
    The occluding device is also capable of altering blood flow to the aneurysm, yet maintaining the desired blood flow to the surrounding tissue and within the vessel. In this instance, some blood is still allowed to reach the aneurysm, but not enough to create a laminar flow within the aneurysm that would cause injury to its thinned walls. Instead, the flow would be intermittent, thereby providing sufficient time for blood clotting or filler material curing within the aneurysm.
  • [0018]
    The occluding device is flexible enough to closely approximate the native vasculature and conform to the natural tortuous path of the native blood vessels. One of the significant attributes of the occluding device according to the present invention is its ability to flex and bend, thereby assuming the shape of a vasculature within the brain. These characteristics are for a neurovascular occluding device than compared to a coronary stent, as the vasculature in the brain is smaller and more tortuous.
  • [0019]
    In general terms, aspects of the present invention relate to methods and devices for treating aneurysms. In particular, a method of treating an aneurysm with a neck comprises deploying a vascular occluding device in the lumen of a vessel at the location of the aneurysm, whereby the blood flow is redirected away from the neck of the aneurysm. The induced stagnation of the blood in the lumen of the aneurysm would create embolization in the aneurysm. The occluding device spans the width of the stem of the aneurysm such that it obstructs or minimizes the blood flow to the aneurysm. The occluding device is very flexible in both its material and its arrangement. As a result, the occluding device can be easily navigated through the tortuous blood vessels, particularly those in the brain. Because the occluding device is flexible, very little force is required to deflect the occluding device to navigate through the vessels of the neurovasculature, which is of significance to the operating surgeon.
  • [0020]
    A feature of the occluding device, apart from its flexibility, is that the occluding device may have an asymmetrical braid pattern with a higher concentration of braid strands or a different size of braid strands on the surface facing the neck of the aneurysm compared to the surface radially opposite to it. In one embodiment, the surface facing the aneurysm is almost impermeable and the diametrically opposed surface is highly permeable. Such a construction would direct blood flow away from the aneurysm, but maintain blood flow to the side branches of the main vessel in which the occluding device is deployed.
  • [0021]
    In another embodiment, the occluding device has an asymmetrical braid count along the longitudinal axis of the occluding device. This provides the occluding device with a natural tendency to curve, and hence conform to the curved blood vessel. This reduces the stress exerted by the occluding device on the vessel wall and thereby minimizing the chances of aneurysm rupture. Additionally, because the occluding device is naturally curved, this eliminates the need for the tip of the micro-catheter to be curved. Now, when the curved occluding device is loaded on to the tip of the micro-catheter, the tip takes the curved shape of the occluding device. The occluding device could be pre-mounted inside the micro-catheter and can be delivered using a plunger, which will push the occluding device out of the micro-catheter when desired. The occluding device could be placed inside the micro-catheter in a compressed state. Upon exiting the micro-catheter, it could expand to the size of the available lumen and maintain patency of the lumen and allow blood flow through the lumen. The occluding device could have a lattice structure and the size of the openings in the lattice could vary along the length of the occluding device. The size of the lattice openings can be controlled by the braid count used to construct the lattice.
  • [0022]
    According to one aspect of the invention, the occluding device can be used to remodel an aneurysm within the vessel by, for example, neck reconstruction or balloon remodeling. The occluding device can be used to form a barrier that retains occlusion material within the aneurysm so that introduced material will not escape from within the aneurysm due to the lattice density of the occluding device in the area of the aneurysm.
  • [0023]
    In another aspect of the invention, a device for occluding an aneurysm is disclosed. The device is a tubular with a plurality of perforations distributed on the wall of the member. The device is placed at the base of the aneurysm covering the neck of the aneurysm such that the normal flow to the body of the aneurysm is disrupted and thereby generating thrombus and ultimately occlusion of the aneurysm.
  • [0024]
    In yet another aspect of this invention, the device is a braided tubular member. The braided strands are ribbons with rectangular cross section, wires with a circular cross section or polymeric strands.
  • [0025]
    In another embodiment, a device with a braided structure is made in order to conform to a curved vessel in the body, where the density of the braid provides enough rigidity and radial strength. Additionally, the device can be compressed using a force less than 10 grams. This enables the device to be compliant with the artery as the arterial wall is pulsating. Also, the device is capable of bending upon applying a force of less than 5 gram/cm.
  • [0026]
    Other aspects of the invention include methods corresponding to the devices and systems described herein.
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • [0027]
    The invention has other advantages and features which will be more readily apparent from the following detailed description of the invention and the appended claims, when taken in conjunction with the accompanying drawings, in which:
  • [0028]
    FIG. 1 is an illustration of an aneurysm, branch vessels and blood flow to the aneurysm.
  • [0029]
    FIGS. 2A and 2B illustrate one embodiment of an occluding device to treat aneurysms.
  • [0030]
    FIG. 3 is an illustration of the embodiment shown in FIG. 2 in a compressed state inside a micro-catheter.
  • [0031]
    FIG. 4A is another embodiment of an occluding device for treating aneurysms.
  • [0032]
    FIGS. 4B and 4C illustrate cross sections of portions of ribbons that can be used to form the occluding device of FIG. 4A.
  • [0033]
    FIG. 5 shows the occluding device in a compressed state inside a micro-catheter being advanced out of the micro-catheter using a plunger.
  • [0034]
    FIG. 6 shows the compressed occluding device shown in FIG. 5 deployed outside the micro-catheter and is in an expanded state.
  • [0035]
    FIG. 7 shows the deployed occluding device inside the lumen of a vessel spanning the neck of the aneurysm, a bifurcation and branch vessels.
  • [0036]
    FIG. 8 is a schematic showing the occluding device located in the lumen of a vessel and the change in the direction of the blood flow.
  • [0037]
    FIG. 9 shows the effect of a bending force on a conventional stent compared to the occluding device of the present invention.
  • [0038]
    FIG. 10 demonstrates the flexibility of the current invention, compared to a traditional stent, by the extent of the deformation for an applied force.
  • [0039]
    FIG. 11 shows the non-uniform density of the braid that provides the desired curved occluding device.
  • [0040]
    FIG. 12 illustrates the difference in lattice density or porosity due to the non-uniform density of the braiding of the occluding device.
  • [0041]
    FIG. 13 shows the varying lattice density occluding device covering the neck of an aneurysm.
  • [0042]
    FIGS. 14 and 15 show an embodiment of the vascular occluding device where the lattice density is asymmetrical about the longitudinal axis near the aneurysm neck.
  • [0043]
    FIG. 16 illustrates a bifurcated occluding device according to an embodiment of the present invention in which two occluding devices of lesser densities are combined to form a single bifurcated device.
  • [0044]
    FIG. 17 illustrates an example of a mesh pattern of a lattice in an occluding device.
  • [0045]
    FIG. 18 illustrates an example of a braiding element of a lattice in an occluding device.
  • [0046]
    FIG. 19 illustrates an example of another braiding element of a lattice in an occluding device.
  • [0047]
    FIG. 20 illustrates a braiding element of an occluding device fitted into a vessel diameter.
  • [0048]
    FIG. 21 is a cross sectional view of an example of a protective coil.
  • [0049]
    FIG. 22 illustrates an example of determining ribbon dimensions of an occluding device in a protective coil or a delivery device.
  • [0050]
    FIG. 23 illustrates another example of determining ribbon dimensions of an occluding device in a protective coil or a delivery device.
  • [0051]
    FIG. 24 illustrates an example of determining a ribbon width based on a number of ribbons.
  • [0052]
    FIG. 25 illustrates a relationship between the PPI of the occluding device in a vessel versus the PPI of the occluding device in a free-standing state.
  • [0053]
    FIG. 26 illustrates an example of a maximum ribbon size that fits in a protective coil.
  • [0054]
    FIG. 27 is a graph showing the opening sizes of braiding elements in the occluding device as a function of the PPI of the lattice structure.
  • [0055]
    FIG. 28 illustrates the in-vessel PPI as a function of the braided PPI of a 32 ribbon occluding device
  • [0056]
    FIG. 29 illustrates the percent coverage as a function of the braided PPI for a 32 ribbon occluding device.
  • [0057]
    FIG. 30 illustrates the opening sizes of braiding elements in the occluding device as a function of the braided PPI of the lattice structure for a 32 ribbon occluding device.
  • DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
  • [0058]
    The devices shown in the accompanying drawings are intended for treating aneurysms. They are generally deployed, using micro-catheters, at the location of a cerebral aneurysm that is intended to be treated. One such system is disclosed in copending U.S. patent application titled “System and Method for Delivering and Deploying an Occluding Device Within a Vessel”, U.S. Ser. No. 11/136,398 filed on May 25, 2005, which is incorporated herein by reference in its entirety. The embodiments of the endovascular occluding device according to aspects of the present invention is useful for treating cerebral aneurysms that are commonly treated using surgical clips, microcoils or other embolic devices.
  • [0059]
    FIG. 1 illustrates a typical cerebral aneurysm 10 in the brain. A neck 11 of the aneurysm 10 can typically define an opening of between about 2 to 25 mm. As is understood, the neck 11 connects the vessel 13 to the lumen 12 of the aneurysm 10. As can be seen in FIG. 1, the blood flow 1 within the vessel 13 is channeled through the lumen 12 and into the aneurysm. In response to the constant blood flow into the aneurysm, the wall 14 of lumen 12 continues to distend and presents a significant risk of rupturing. When the blood within the aneurysm 10 causes pressure against the wall 14 that exceeds the wall strength, the aneurysm ruptures. The present invention could prevent such ruptures. Also shown in FIG. 1 are the bifurcation 15 and the side branches 16.
  • [0060]
    FIG. 2 illustrates one embodiment of a vascular occluding device 20 in accordance with an aspect of the present invention. In the illustrated embodiment, the occluding device 20 has a substantially tubular structure 22 defined by an outer surface 21, an inner surface 24 and a thin wall that extends between the surfaces 21, 24. A plurality of openings 23 extend between the surfaces 21, 24 and allow for fluid flow from the interior of the occluding device 20 to the wall of the vessel. Occluding device 20 is radially compressible and longitudinally adjustable.
  • [0061]
    FIG. 3 shows a micro-catheter 25 and the occluding device 20 inside the micro-catheter 25 in a compressed state prior to being released within the vasculature of the patient.
  • [0062]
    FIG. 4 illustrates another embodiment of the occluding device 30 having two or more strands of material(s) 31, 32 wound in a helical fashion. The braiding of such material in this fashion results in a lattice structure 33. As can be understood, the dimension of the lattice 33 and the formed interstices 34 is determined, at least in part, by the thickness of the strand materials, the number of strands and the number of helices per unit length of the occluding device 30. For example, the interstices 34 and/or the dimension of the lattice 33 may be determined by the number of strands of material(s) 31, 32 wound in helical fashion. In one example, any number of braiding ribbons up to 16 braiding ribbons may be used (e.g., 5, 8, 10, 13, 15 or 16 braiding ribbons). In another example, 16-32 braiding ribbons may be used (e.g., 20, 23, 25, 27, 30, or 32 braiding ribbons). In another example greater than 32 braiding ribbons may be used such as, for example, 35, 40, 48, 50, 55, 60, 80, 100, or greater braiding ribbons. Nevertheless, other values are possible.
  • [0063]
    Hence, strands of material, such as ribbons, may intersect to form a braid pattern. The intersection of the strand material may be formed in either a radial or axial direction on a surface of a forming device such as a braiding mandrel. When the intersection of the strand material is along an axial path, for example, the intersecting material may be at a fixed or variable frequency. As one example of strand material intersecting at a fixed frequency, the intersecting strand material may be along any 1.0 inch axial path on the surface of the forming device (e.g., a braiding mandrel) to indicate the pick count. When the intersection of the strand material is along a radial path or circumferential path, the spacing of the strand material may be uniformly or variably distributed. In one example of the strand material along a radial or circumferential path in which the spacing is uniformly distributed, the spacing along the radial direction may be determined based on the following formula:
    (π)*(forming device diameter)/(# ribbons/2)  Eq. (1):
  • [0064]
    FIG. 18 illustrates an example of braiding elements or cells in the radial and PPI (picks per inch) directions. Any single element of the braid (i.e., braid element) may be combined to form a mesh pattern as illustrated in FIG. 17 on a surface of a forming device (e.g., braiding mandrel). The braid is capable of impeding or disrupting the flow of fluid (e.g., blood) in a vessel (e.g., blood vessel). The braid or lattice pattern, density, shape, etc. when the occluding device is deployed in the vessel, may at least partially determine the flow within the vessel. Each of the parameters of the braid or lattice may also be controlled by a user to control flow.
  • [0065]
    Parameters for determining the flow through an occluding device containing a lattice pattern, density, shape, etc. include surface coverage of the occluding device and cell size of the braid or lattice pattern. Each of these parameters may further characterize the geometry of the braid or lattice. Surface coverage may be determined as (surface area)/(total surface area), where the surface area is the surface area of the frame or solid element and the total surface area is of the entire element (i.e., frame and opening).
  • [0066]
    Cell size may be determined as the maximum length defining a cell opening. Braiding patterns that increase surface coverage while decreasing cell size may have an increased effect on disrupting or impeding the flow through the braid or lattice. Each of the parameters of surface coverage and cell size may further be enhanced by varying the width of the strand material (e.g., the ribbons), increasing the number of strands of strand material defining the braid, and/or increasing the PPI (i.e., Picks Per Inch).
  • [0067]
    The braiding or lattice pattern as described may be further defined by various parameters including, for example, the number of strands (e.g., ribbons), the width of each ribbon/strand, the braiding PPI, and/or the diameter of the forming device (e.g., mandrel diameter), to name a few. Based on the lattice parameters, a leg length and a ribbon angle may be determined. The leg length may define the length of an aspect of the braiding element. For example, if the braiding element is diamond shaped as illustrated in FIG. 17, the length of one side of the diamond shaped braiding element is the “leg length.” A ribbon angle may define the angle created by two intersecting aspects of the braiding element. In the example illustrated in FIG. 17, the ribbon angle is the angle formed between two adjacent sides of the diamond shaped braiding element. Radial spacing of braid elements in a lattice pattern can define the width of a braiding element in radial direction. FIG. 18 illustrates an example of a radial spacing, leg length and ribbon angle of a braid element.
  • [0068]
    Radial spacing of the lattice may be determined as set forth in Equation 1 as follows:
    Radial Spacing (π)*(forming device diameter)/(# ribbons/2)  Eq. (1):
  • [0069]
    The braiding element may be fitted into a vessel based on the radial spacing or the diameter of the vessel. The radial spacing of the lattice may be adjusted based on the diameter of the vessel. For example, if the diameter of the vessel is small, the radial spacing may be adjusted to a smaller dimension while the leg length of the braid elements may be maintained. Also in this example, the ribbon angle may also be adjusted to achieve the adjusted radial spacing. Adjusting the ribbon angle may also alter the spacing of the braid element in the PPI direction.
  • [0070]
    FIG. 19 illustrates an example of determining a radial spacing and ribbon angle of a lattice structure in an occluding device. In this example, a lattice or braid contains sixteen interlacing ribbons, with each ribbon being 0.004 inches wide and braided on a forming device such as a mandrel with a diameter of 4.25 mm and 65 PPI. Thus, in this example, the number of braiding elements is sixteen, the ribbon width is 0.004 inches, the spacing in the PPI direction is 1/65=0.01538 inches and the diameter of the forming device (e.g., mandrel diameter) is 4.25 mm. Hence, the radial spacing may be calculated as: Radial spacing=(π)*(forming device diameter)/(# ribbons/2)=(3.14)*(0.425/2.54)/(16/2)=0.0657 inches. FIG. 19 illustrates an example of a braiding element with a radial spacing of 0.0657 inches. In addition, the leg length of the example is 0.0337 inches, the ribbon angle is 153.65 degrees, and the spacing of the braiding element in the PPI direction, based on the ribbon angle and leg length is 0.0154 inches.
  • [0071]
    FIG. 20 illustrates the example of FIG. 19 after the braiding element is fitted into an appropriate vessel diameter. In this example, the radial spacing is adjusted to a smaller length to accommodate a smaller vessel diameter. The leg length remains constant at 0.0337 inches so the ribbon angle changes based on changes in the radial spacing. In this example, the radial spacing is adjusted to 0.06184 inches and the ribbon angle is adjusted to 132.79 degrees. Also, the spacing of the braid element in the PPI direction is also changed. In this example, the spacing of the braid element in the PPI direction increases from 0.0154 inches to 0.0270 inches.
  • [0072]
    Table 1 illustrates additional examples of lattice or braid patterns of varying PPI, ribbon width (RW), or number of ribbons. In addition, each of the braid patterns in Table 1 may produce patterns with the same percent coverage within a vessel.
    TABLE 1
    # ribbons 16 32 64
    Braid diameter (mm) 4.25 4.25 4.25
    Braid diameter (in) 0.16732 0.16732 0.16732
    PPI 65.00 130.00 260.00
    RW (mils) 4.0000 2.0000 1.0000
    Node Spacing (ppi) 0.01538 0.00769 0.00385
    Node Spacing (radial) 0.06571 0.03285 0.01643
    Ribbon Angle (ppi) 153.65 153.65 153.62
    Leg Length (in) 0.03374 0.01687 0.00844
    Vessel diameter (mm) 4 4 4
    In-vessel device Node spacing 0.06184 0.03092 0.01546
    In-vessel device Ribbon Angle (ppi) 132.79 132.79 132.70
    In-vessel device Node spacing 0.02702 0.01351 0.00677
    (ppi)
    In-vessel device PPI 37.01 74.04 147.72
    In-vessel device braided closed 0.00024814 0.00006203 0.00001551
    area (in2)
    In-vessel device Braided Open 0.00058741 0.00014680 0.00003681
    Area (in2)
    In-vessel device coverage 29.7% 29.7% 29.64%
    In-vessel device total area (in2) 0.00083555 0.00020883 0.00005232
    In-vessel device cell size (mm) 1.317 0.658 0.329
  • [0073]
    The occluding device may be placed into a protective coil to enhance placement of the occluding device in a vessel. Also, the occluding device may be housed in a delivery device, such as a catheter, for placement within a vessel. The occluding device may be created at a size or dimension based on the size of the protective coil, delivery device, or catheter housing the occluding device. For example, the number of strands or ribbons in the lattice structure of the occluding device that fit into a corresponding protective coil, delivery device, or catheter may be determined such that the occluding device is effectively stored or housed prior to deployment in a vessel. In one example, the strands of the occluding device may overlap in a 2-layer structure including an inner layer and an outer layer, the outer layer contacting the protective coil.
  • [0074]
    In one example, a housing such as a protective coil, delivery device or catheter that houses the occluding device may have a constant size or diameter and the characteristics of the occluding device may be determined to fit the housing. For example, a ribbon size or width may be determined based on the desired size of the housing. In this way, the size (or diameter) of the housing (e.g., protective coil, delivery device or catheter) may be constant for a variety of occluding devices that may vary in size or number of ribbons.
  • [0075]
    FIG. 21 illustrates an example of a cross sectional view of a protective coil. In this example, a number of strands or ribbons in a lattice structure of an occluding device is determined for a protective coil. The protective coil illustrated in FIG. 21 has a circular cross sectional area with a diameter. A strand or ribbon of a predetermined thickness or size is placed within the protective coil such that the outer surface of the strand/ribbon contact the inner surface of the protective coil. The inner surface of the strand/ribbon creates a concave surface within the protective coil. A second strand/ribbon is placed within the protective coil such that the outer surface of the second strand/ribbon contacts an inner circumference in contact with the the concave surface of the strand/ribbon previously placed in the protective coil. The angle from a center point of the circular protective coil from one edge of the second strand/ribbon to an opposite edge of the second strand/ribbon is determined (i.e., the “arc-angle”). Based on these measurements, the number of strands or ribbons of the predetermined size or thickness may be determined as follows: (Arc-angle)*(# ribbons/2)<=360 degrees (i.e., # ribbons<=720 degrees/angle).
  • [0076]
    In the example illustrated in FIG. 21, an occluding device is constructed using a 0.001 by 0.004 inch ribbon. The arc-angle of the ribbon element at the center of the protective coil between a first line drawn from the center point of the protective coil to one edge of an inner layer ribbon and a second line drawn from the center point of the protective coil to the opposite edge of the inner layer ribbon is 34.14 degrees. Thus, the calculated number of ribbons is less than or equal to 720 degrees/34.14 degrees=20 ribbons.
  • [0077]
    TABLE 2 illustrates additional examples of different designs for loading a lattice structure of an occluding device in a protective coil.
    TABLE 2
    # ribbons 16 32 64
    Protective Coil ID (in) 0.017 0.017 0.017
    Ribbon Width (in) 0.004 0.002 0.001
    Ribbon Thickness (in) 0.001 0.001 0.001
    Inner Circle Angle 36.98 17.83 8.84
    Max # Ribbons fitting in inner circle 9.73 20.19 40.72
    # ribbons in inner circle 8 16 32
  • [0078]
    FIG. 22 illustrates another example of determining ribbon dimensions for an occluding device in a protective coil or a delivery device. In this example, an occluding device with a lattice or braid structure based on a thickness of a ribbon. As FIG. 22 illustrates, the diameter of the protective coil or delivery device 2301 is 0.0170 inches. A first ribbon 2302 is fitted within the outer surface of the protective coil or delivery device 2301. A second ribbon 2303 is placed in contact with an inner circumference of the protective coil or delivery device 2301 where the inner circumference is a circumference that is tangential to the inner surface of the first ribbon 2302. The second ribbon 2303 is placed within the inner circumference such that lateral ends of the second ribbon 2303 are in contact with the inner circumference of the protective coil or delivery device 2301. The arc-angle between a first line extending from the center point of the protective coil or delivery device 2301 to one lateral end of the second ribbon 2303 and a second line extending from the center point of the protective coil or delivery device 2301 to the other lateral end of the second ribbon 2303 is calculated as illustrated in FIG. 22.
  • [0079]
    In this example, the maximum dimensions of the first and second ribbons 2302, 2303 are determined based on the calculated arc-angle formed. For example, to allow eight ribbons in the inner circumference of the protective coil or delivery device 2301, the arc-angle may be calculated as (360 degrees)/8=45 degrees as FIG. 22 illustrates. Based on a 45 degree angle, the maximum ribbon width may be determined as 0.00476 inches to allow eight ribbons of a thickness of 0.001 inches to fit within the inner circumference of the protective coil or delivery device 2301.
  • [0080]
    In another example, a narrower ribbon width is used to compensate for material tolerance variations and curvature. Based on extensive research and experimentation by the applicants, it was discovered that a tolerance range applied to the ribbon widths of about 20% can compensate for such material tolerance variations. FIG. 23 illustrates an example of a 20% tolerance range or cushion applied to ribbon widths of an occluding device.
  • [0081]
    In this example, 20% additional ribbons are desired in the occluding device (i.e., 1.20*8=9.6 ribbons). The maximum width of the ribbons may be determined based on the desired number of 9.6 ribbons by calculating the angle as described above. Specifically, the arc-angle may be calculated as (360 degrees)/9.6=37.7 degrees. Based on this calculation, the maximum width of the ribbons may be determined as 0.00405 inches as illustrated in FIG. 23. Thus, in this example, a 20% cushion is applied to permit 9.6 ribbons in the protective coil or delivery device at a maximum width of 0.00405 inches.
  • [0082]
    Table 3 provides additional examples of ribbon widths for various ribbon thicknesses. In the examples provided in Table 3, the ribbon thicknesses range from 0.0007 inches to 0.0015 inches.
    TABLE 3
    Ribbon Thickness
    (in) Calculated max width (in) 20% cushion width (in)
    0.0005 0.00543 00.000463
    0.0006 0.00530 0.00452
    0.0007 0.00516 0.00440
    0.0008 0.00503 0.00428
    0.0009 0.00490 0.00417
    0.0010 0.00476 0.00405
    0.0011 0.00463 0.00393
    0.0012 0.00450 0.00382
    0.0013 0.00436 0.00370
    0.0014 0.00422 0.00358
    0.0015 0.00409 0.00346
  • [0083]
    In another example, an occluding device containing 32 ribbons is described. FIG. 24 illustrates an example of determining the ribbon width of a 32-ribbon occluding device based on the number of ribbons that can fit in the protective coil or delivery device 2501. In this example, the protective coil or delivery device 2501 has a diameter of 0.017 inches and the maximum ribbon width that can fit in the inner circumference of the protective coil or delivery device 2501 provides an arc-angle of (360 degrees)/(32/2)=22.5 degrees as illustrated in FIG. 24. Hence, to fit 16 ribbons along the inner circumference of the protective coil 2501, the width of the ribbons is determined to be 0.00266 inches, with a thickness of 0.00080 inches as illustrated in FIG. 24. Similarly a 20% cushion may be applied to the ribbon widts to provide for narrower ribbon widths to compensate for material tolerance variations. In this example, the modified ribbon widths may be determined based on the new arc-angle requirement of (360 degrees)/19.2=18.75 degrees. Table 4 provides maxiumum ribbon widths for a 32-ribbon occluding device.
    TABLE 4
    Ribbon Thickness
    (in) Calculated max width (in) 20% cushion width (in)
    0.0005 0.00288 0.00242
    0.0006 0.00281 0.00235
    0.0007 0.00273 0.00229
    0.0008 0.00266 0.00223
    0.0009 0.00258 0.00216
    0.0010 0.00251 0.00210
  • [0084]
    Alternatively, a larger number of ribbons may be included in the occluding device. For example, the strands or ribbons may be increased to greater than 32, such as 40, 44, 48, 50, 56, 60, 64, 70, 76, 80, 90, 100, or more. For any desired number of ribbons, a ribbon width may be determined based on a calculated angle or a ribbon thickness as described. In addition, a cushion may be applied to the ribbon width as described.
  • [0085]
    In another example, oversized occluding devices may be used relative to the vessel. For example, a larger occluding device relative to the size of the vessel lumen may result in enhanced anchoring of the occluding device within the lumen of the vessel. FIG. 25 illustrates a relationship between the PPI of the occluding device in place in the vessel (“in-vessel PPI”) versus the PPI of the occluding device in the free-standing state (“braided PPI”). The graph in FIG. 25 demonstrates that for each design, the PPI of the occluding device in place in the vessel approaches a maximum value as the pick count of the occluding device in the free-standing state increases. For example, for the 4 mm vessel design, as the PPI of the free-standing occluding device is increased, the PPI of the occluding device in the vessel increases until the in-vessel PPI reaches about 45. When the in-vessel PPI reaches about 45, further increases in the braided PPI result in only minimal further increases in the in-vessel PPI. Also illustrated in FIG. 25, different vessel designs (e.g., 3 mm vessel design or 5 mm vessel design) result in a similar behavior in which the in-vessel PPI approaches a maximum value for high braided pick counts.
  • [0086]
    Similarly, FIG. 28 illustrates the in-vessel PPI as a function of the braided PPI of a 32 ribbon occluding device. In the examples illustrated in FIG. 28, the PPI of the occluding device in a vessel (“in-vessel PPI”) approaches a maximum value as the PPI of the occluding device in a free-standing state (“braided PPI”). FIG. 28 also illustrates alternate vessel designs. As can be seen in the examples of vessel designs of FIG. 28, for each of the vessel designs, the in-vessel PPI approaches a maximum value asymptotically as the braided PPI increases.
  • [0087]
    Similarly, the coverage of the occluding device may be based on ribbon width or braided PPI. FIG. 26 illustrates an example in which the ribbon is 0.00467 inches wide and 0.001 inches and is the maximum ribbon size that fits in the protective coil. As FIG. 26 illustrates, the coverage approaches a maximum value of approximately 65-100 PPI range. In this example, the percentage of coverage asymptotically approaches approximately 40% for a 0.001″0.00467″ ribbon and 34% for a 0.001″0.004″ ribbon.
  • [0088]
    FIG. 29 illustrates the percent coverage as a function of the braided PPI for a 32 ribbon occluding device. As FIG. 29 demonstrates, the % coverage approaches a maximum value as the braided PPI in increases. For example, for an occluding device containing 0.00080.00266 inch ribbons, the % coverage approaches a maximum value of about 43% as the braided PPI increases above about 150. Also, for an occluding device containing 0.00080.0020 inch ribbons, the % coverage approaches a maximum value of about 35% as the braided PPI increases above about 150.
  • [0089]
    FIG. 27 is a graph showing the opening sizes of braiding elements in the occluding device as a function of the PPI of the lattice structure. As the PPI increases, the opening sizes or spaces through which flow of fluid (e.g., blood) decreases. As the PPI of the lattice structure reaches about 100, the opening sizes of the braiding elements when in place in a vessel asymptotically approaches a minimum value. In the examples illustrated in FIG. 27, for a ribbon size of 0.0010.004 inches, the opening sizes of the braiding elements in the lattice structure of an occluding device in a vessel approaches 1280 microns or less. Similarly, for a ribbon size of 0.0010.00467 inches, the opening sizes of the braiding elements in the lattice structure of an occluding device in a vessel approaches about 1220.
  • [0090]
    FIG. 30 illustrates the opening sizes of braiding elements in the occluding device as a function of the braided PPI of the lattice structure for a 32 ribbon occluding device. As FIG. 30 demonstrates, the opening size of braiding elements approaches a minimum value as the braided PPI in increases. For example, for an occluding device containing 0.00080.00266 inch ribbons, the opening size approaches a minimum value of about less than 600 microns as the braided PPI increases above about 150. Also, for an occluding device containing 0.00080.0020 inch ribbons, the opening sizes approaches a minimum value of about 640 as the braided PPI increases above about 150.
  • [0091]
    The occluding device 30 is radially compressible and radially expandable without the need for supplemental radially expanding force, such as an inflatable balloon. The occluding device 30 is constructed by winding the two strands (31, 32 in opposite directions. Alternatively, greater than 2 strands may be wound in various directions. For example, 8, 10, 12, 14, 22, 28, 30, 32, 36, 40, 44, 48, 52, 58, 64, 70, 86, 90, 110, 116, 120, 128, 136, 150, or greater strands may be wound in various directions. In an embodiment, the strands 31, 32 are in the shape of rectangular ribbon (See FIG. 4C). The ribbons can be formed of known flexible materials including shape memory materials, such as Nitinol, platinum and stainless steel.
  • [0092]
    The ribbon used as the braiding material for the strands 31, 32 can include a rectangular cross section 35 (FIG. 4C). As shown in FIGS. 4C and 7, the surface 36 that engages an inner surface of the vessel has a longer dimension (width) when compared to the wall 38 that extends between the surfaces 36, 37 (thickness). A ribbon with rectangular cross section has a higher recovery (expansive) force for the same wall thickness when compared to a wire with a circular (round) cross section. Additionally, a flat ribbon allows for more compact compression of the occluding device 20 and causes less trauma to the vascular wall when deployed because it distributes the radial expansion forces over a greater surface area. Similarly, flat ribbons form a more flexible device for a given lattice density because their surface area (width) is greater for a given thickness in comparison to round wire devices.
  • [0093]
    While the illustrated embodiment discloses a ribbon having a rectangular cross section in which the length is greater than its thickness, the ribbon for an alternative embodiment of the disclosed occluding devices may include a square cross section. In another alternative embodiment, a first portion of the ribbon may include a first form of rectangular cross section and a second portion 39 of the ribbon (FIG. 4B) may include a round, elliptical, oval or alternative form of rectangular cross section. For example, end sections of the ribbons may have substantially circular or oval cross section and the middle section of the ribbons could have a rectangular cross section.
  • [0094]
    In an alternative embodiment as described above, the occluding device 30 can be formed by winding more than two strands of ribbon. In an embodiment, the occluding device 30 could include as many as sixteen strands of ribbon. In another embodiment, the occluding device 30 can include as many as 32 strands of ribbon, as many as 48 strands of ribbon, as many as 60 strands of ribbon, as many as 80 strands of ribbon, as many as 100 strands of ribbon, as many as 150 strands of ribbon or greater than 150 strands of ribbon, for example. By using standard techniques employed in making radially expanding stents, one can create an occluding device 30 with interstices 34 that are larger than the thickness of the ribbon or diameter of the wire. The ribbons can have different widths. In such an embodiment, the different ribbon(s) can have different width(s) to provide structure support to the occluding device 30 and the vessel wall. The ribbons according to the disclosed embodiments can also be formed of different materials. For example, one or more of the ribbons can be formed of a biocompatible metal material, such as those disclosed herein, and one or more of the ribbons can be formed of a biocompatible polymer.
  • [0095]
    FIG. 5 shows the intravascular occluding device 30 in a radially compressed state located inside the micro-catheter 25. In one embodiment, the occluding device 30 could be physically attached to the catheter tip. This could be accomplished by constraining the occluding device 30 in the distal segment of the micro-catheter. The micro-catheter 25 is slowly advanced over a guidewire (not shown) by a plunger 50 and when the tip of the micro-catheter 25 reaches the aneurysm, the occluding device is released from the tip. The occluding device 30 expands to the size of the vessel and the surface of the occluding device 30 is now apposed to the vessel wall 15 as shown in FIG. 6. Instruments and methods for delivering and deploying the occluding device 30 are disclosed in the above-referenced copending application.
  • [0096]
    With reference to FIG. 7, the occluding device 30 is deployed inside the lumen of a cerebral vessel 13 with an aneurysm 10. During its deployment, the proximal end 43 of the occluding device 30 is securely positioned against the lumen wall of the vessel 13 before the bifurcation 15 and the distal end 45 of the occluding device 30 is securely positioned against the lumen wall of the vessel 13 beyond the neck 11 of aneurysm 10. After the occluding device 30 is properly positioned at the desired location within the vessel 13 (for example, see FIG. 7), flow inside the lumen of aneurysm 10 is significantly minimized while the axial flow within the vessel 13 is not significantly compromised, in part due to the minimal thickness of the walls 38.
  • [0097]
    The flow into the aneurysm 10 will be controlled by the lattice density of the ribbons and the resulting surface coverage. Areas having greater lattice densities will have reduced radial (lateral) flow. Conversely, areas of lesser lattice densities will allow significant radial flow through the occluding device 30. As discussed below, the occluding device 30 can have longitudinally extending (lateral) areas of different densities. In each of these areas, their circumferential densities can be constant or vary. This provides different levels of flow through adjacent lateral areas. The location within a vessel of the areas with greater densities can be identified radiographically so that the relative position of the occluding device 30 to the aneurysm 10 and any vascular branches 15, 16 can be determined. The occluding device 30 can also include radiopaque markers.
  • [0098]
    The reduction of blood flow within the aneurysm 10 results in a reduction in force against the wall 14 and a corresponding reduction in the risk of vascular rupturing. When the force and volume of blood entering the aneurysm 10 is reduced by the occluding device, the laminar flow into the aneurysm 10 is stopped and the blood within the aneurysm begins to stagnate. Stagnation of blood, as opposed to continuous flow through the lumen 12 of the aneurysm 10, results in thrombosis in the aneurysm 10. This also protects the aneurysm from rupturing. Additionally, due to the density of the portion of the occluding device 30 at the bifurcation 15, the openings (interstices) 34 in the occluding device 30 allow blood flow to continue to the bifurcation 15 and the side branches 16 of the vessel. If the bifurcation 15 is downstream of the aneurysm, as shown in FIG. 8, the presence of the occluding device 30 still channels the blood away from the aneurysm 10 and into the bifurcation 15.
  • [0099]
    The occluding devices described herein have flexibility to conform to the curvature of the vasculature. This is in contrast to coronary stents that cause the vasculature to conform essentially to their shape. The ability to conform to the shape of the vasculature is more significant for neurovascular occluding devices than coronary stents, as the vasculature in the brain is smaller and more tortuous. Tables 5 and 6 demonstrate these characteristics of the claimed neurovascular occluding device. To demonstrate that the disclosed occluding devices exhibit very desirable bending characteristics, the following experiment was performed. The occluding device made by the inventors was set on a support surface 90 as shown in FIG. 9. About 0.5 inches of the occluding device 30 was left unsupported. Then, a measured amount of force was applied to the unsupported tip until the occluding device was deflected by 90 degrees from the starting point. A similar length of a commercially available coronary stent was subjected to the same bending moment. The results are shown in Table 5. Similar to the reduced compressive force, the occluding device of the present invention required an order of magnitude lower bending moment (0.005 lb-in compared to 0.05 lb-in for a coronary stent).
    TABLE 5
    Bending Force Required to Bend a 0.5″ Cantilever Made
    by the Occlusion Device
    Coronary stent commercially available stent 0.05 lb-in
    Neurovascular Occluding Device (30) 0.005 lb-in
  • [0100]
    The occluding devices according to the present invention also provides enhanced compressibility (i.e., for a given force how much compression could be achieved or to achieve a desired compression how much force should be exerted) compared to coronary stents. An intravascular device that is not highly compressible is going to exert more force on the vessel wall compared to a highly compressible device. This is of significant clinical impact in the cerebral vasculature as it is detrimental to have an intravascular device that has low compressibility.
    TABLE 6
    Compressive Force Required to Compress the Occluding device
    to 50% of the Original Diameter (see FIG. 10)
    Coronary stem (commercially available  0.2 lb
    Neurovascular Occluding device (30) 0.02 lb
  • [0101]
    FIGS. 11-13 show an embodiment of the occluding device 60 in which the lattice structure 63 of the occluding device 60 is non-uniform across the length of the occluding device 60. In the mid-section 65 of the occluding device 60, which is the section likely to be deployed at the neck of the aneurysm, the lattice density 63 a is intentionally increased to a value significantly higher than the lattice density elsewhere in the occluding device 60. For example, as seen in FIG. 11, lattice density 63A is significantly higher than the lattice density 63 in adjacent section 64. At one extreme, the lattice density (porosity provided by the interstices) could be zero, i.e., the occluding device 60 is completely impermeable. In another embodiment, the lattice density 63A in mid-section 65 could be about 50%, while the lattice density in the other sections 64 of the occluding device is about 25%. FIG. 12 shows such an occluding device 60 in a curved configuration and FIG. 13 shows this occluding device 60 deployed in the lumen of a vessel. FIG. 13 also illustrates the part of the occluding device 60 with increased lattice density 63A positioned along the neck of aneurysm 10. As with any of the disclosed occluding devices, the lattice density of at least one portion of occluding device 60 can be between about 20% and about 80%. The lattice density of these embodiments could be between about 25% and about 50%.
  • [0102]
    Another embodiment of the occluding device 300 is shown in FIGS. 14 and 15. In this embodiment, the occluding device 300 is deployed in lumen of a vessel with an aneurysm. The occluding device 300 includes a surface 310 that faces the lumen of the aneurysm. This surface 310 has a significantly higher lattice density (smaller and/or fewer interstices) compared to the diametrically opposite surface 320. Due to the higher lattice density of surface 310, less blood flows into the lumen of the aneurysm. However, there is no negative impact on the blood flow to the side branches as the lattice density of the surface 320 facing the side branches is not reduced.
  • [0103]
    Any of the occluding devices disclosed herein can be used with a second occluding device to create a bifurcated occluding device 400 as shown in FIG. 16. This device could be created in vivo. In forming the occluding device 400, a portion of a first occluding device 410 having a low density can be combined with a portion of a second occluding device 410 that also has a low density. The occluding devices 410, 420 can be any of those discussed herein. After these portions of the two occluding devices 410, 420 are combined in an interwoven fashion to form an interwoven region 425, the remaining portions 414, 424 can branch off in different directions, thereby extending along two braches of the bifurcation. Areas outside of the interwoven region 425 can have greater lattice density for treating an aneurysm or lesser lattice density for allowing flow to branches 15, 16 of the vessel.
  • [0104]
    The density of the lattice for each of the disclosed occluding devices can be about 20% to about 80% of the surface area of its occluding device. In an embodiment, the lattice density can be about 20% to about 50% of the surface area of its occluding device. In yet another embodiment, the lattice density can be about 20% to about 305 of the surface area of its occluding device.
  • [0105]
    A typical occluding device having sixteen strand braids with 0.005 inch wide ribbon, 30 picks per inch (PPI) (number of crosses/points of contact per inch), and 0.09 inch outer diameter has approximately 30% of lattice density (surface covered by the ribbon). In the embodiments disclosed herein, the ribbon can be about 0.001 inch thick with a width of between about 0.002 inch to about 0.005 inch. In an embodiment, the ribbon has a thickness of about 0.004 inch. For a 16-strands ribbon that is about 0.001 inch thick and about 0.004 inch wide, the coverage for 50 PPI, 40 PPI, and 30 PPI will have 40%, 32% and 24% approximate surface coverage, respectively. For a 16-strands ribbon that is about 0.001 inch thick and about 0.005 inch wide, the coverage for 50 PPI, 40 PPI, and 30 PPI will be about 50%, 40% and 30% approximate surface coverage, respectively.
  • [0106]
    In choosing a size for the ribbon, one must consider that, when the ribbons are bundled up, will they traverse through a micro-catheter. For example, sixteen strands of a 0.006 inch wide ribbon may not pass through a micro-catheter having an internal diameter of 0.027 inch or less. However, as the width of ribbons become smaller, the recovery strength may decrease proportionally.
  • [0107]
    While other strand geometry may be used, these other geometries, such as round, will limit the device due to their thickness dimension. For example, a round wire with a 0.002 inch diameter will occupy up to 0.008 inch in cross sectional space within the vessel. This space can impact and disrupt the blood flow through the vessel. The flow in the vessel can be disrupted with this change in diameter.
  • [0108]
    Although the detailed description contains many specifics, these should not be construed as limiting the scope of the invention but merely as illustrating different examples and aspects of the invention. It should be appreciated that the scope of the invention includes other embodiments not discussed in detail above. Various other modifications, changes and variations which will be apparent to those skilled in the art may be made in the arrangement, operation and details of the method and apparatus of the present invention disclosed herein without departing from the spirit and scope of the invention as defined in the appended claims. Therefore, the scope of the invention should be determined by the appended claims and their legal equivalents. Furthermore, no element, component or method step is intended to be dedicated to the public regardless of whether the element, component or method step is explicitly recited in the claims.
  • [0109]
    In the claims, reference to an element in the singular is not intended to mean “one and only one” unless explicitly stated, but rather is meant to mean “one or more.” In addition, it is not necessary for a device or method to address every problem that is solvable by different embodiments of the invention in order to be encompassed by the claims.
Patent Citations
Cited PatentFiling datePublication dateApplicantTitle
US4321711 *Oct 12, 1979Mar 30, 1982Sumitomo Electric Industries, Ltd.Vascular prosthesis
US4655771 *Apr 11, 1983Apr 7, 1987Shepherd Patents S.A.Prosthesis comprising an expansible or contractile tubular body
US5180368 *Oct 11, 1991Jan 19, 1993Advanced Cardiovascular Systems, Inc.Rapidly exchangeable and expandable cage catheter for repairing damaged blood vessels
US5192297 *Dec 31, 1991Mar 9, 1993Medtronic, Inc.Apparatus and method for placement and implantation of a stent
US5201757 *Apr 3, 1992Apr 13, 1993Schneider (Usa) Inc.Medial region deployment of radially self-expanding stents
US5209731 *Dec 13, 1991May 11, 1993Endovascular Technologies, Inc.Hand-held gun for inflating and aspirating large volume balloons
US5405380 *Jul 27, 1993Apr 11, 1995Schneider (Europe) A.G.Catheter with a vascular support
US5415637 *Apr 14, 1993May 16, 1995Advanced Cardiovascular Systems, Inc.Temporary stenting catheter with drug delivery capabilities
US5480423 *May 20, 1993Jan 2, 1996Boston Scientific CorporationProsthesis delivery
US5489295 *May 21, 1993Feb 6, 1996Endovascular Technologies, Inc.Endovascular graft having bifurcation and apparatus and method for deploying the same
US5507768 *Jul 6, 1993Apr 16, 1996Advanced Cardiovascular Systems, Inc.Stent delivery system
US5591225 *Nov 23, 1994Jan 7, 1997Vascular Craft Research Center Co., Ltd.Composite artificial blood vessel
US5607466 *Apr 28, 1995Mar 4, 1997Schneider (Europe) A.G.Catheter with a stent
US5609625 *Dec 10, 1993Mar 11, 1997Endovascular Technologies, Inc.Endovascular graft having bifurcation and apparatus and method for deploying the same
US5626602 *Jan 17, 1995May 6, 1997Schneider (Europe) A.G.Catheter with a vascular support
US5709702 *Oct 15, 1996Jan 20, 1998Cogita; GiuseppeSurgical device for repairing aneurysms
US5725570 *Feb 29, 1996Mar 10, 1998Boston Scientific CorporationTubular medical endoprostheses
US5735859 *Feb 14, 1997Apr 7, 1998Cathco, Inc.Distally attachable and releasable sheath for a stent delivery system
US5741325 *May 3, 1996Apr 21, 1998Emory UniversitySelf-expanding intraluminal composite prosthesis
US5868754 *Jun 12, 1996Feb 9, 1999Target Therapeutics, Inc.Medical retrieval device
US5888201 *Jun 13, 1997Mar 30, 1999Schneider (Usa) IncTitanium alloy self-expanding stent
US6019778 *Mar 13, 1998Feb 1, 2000Cordis CorporationDelivery apparatus for a self-expanding stent
US6024763 *May 22, 1997Feb 15, 2000Medtronic, Inc.Apparatus and methods for deployment release of intraluminal prostheses
US6027516 *May 4, 1995Feb 22, 2000The United States Of America As Represented By The Department Of Health And Human ServicesHighly elastic, adjustable helical coil stent
US6039758 *Dec 22, 1997Mar 21, 2000Endovascular Technologies, Inc.Method for intraluminally deploying a bifurcated graft
US6042589 *May 29, 1998Mar 28, 2000Medicorp, S.A.Reversible-action endoprosthesis delivery device
US6051021 *May 26, 1998Apr 18, 2000Medicorp, S.A.Self-expanding endoprosthesis
US6168592 *Apr 23, 1999Jan 2, 2001Target Therapeutics, Inc.Aneurysm closure device assembly
US6183410 *May 6, 1999Feb 6, 2001Precision Vascular Systems, Inc.Radiation exposure device for blood vessels, body cavities and the like
US6197046 *Sep 20, 1999Mar 6, 2001Endovascular Technologies, Inc.Method for deploying an endovascular graft having a bifurcation
US6210400 *Oct 2, 1998Apr 3, 2001Endovasix, Inc.Flexible flow apparatus and method for the disruption of occlusions
US6210434 *Jul 14, 1999Apr 3, 2001Endovascular Technologies, Inc.Multicapsule intraluminal grafting system and method
US6210435 *Aug 17, 1999Apr 3, 2001Endovascular Technologies, Inc.Endovascular graft having bifurcation and apparatus and method for deploying the same
US6214038 *Sep 15, 1999Apr 10, 2001Endovascular Technologies, Inc.Method for deploying an endovascular graft having a bifurcation
US6214042 *Nov 10, 1998Apr 10, 2001Precision Vascular Systems, Inc.Micro-machined stent for vessels, body ducts and the like
US6221102 *Jun 7, 1995Apr 24, 2001Endovascular Technologies, Inc.Intraluminal grafting system
US6344041 *Oct 26, 2001Feb 5, 2002David KupieckiAneurysm closure device assembly
US6348063 *Jan 18, 2000Feb 19, 2002Mindguard Ltd.Implantable stroke treating device
US6350199 *Mar 16, 1999Feb 26, 2002International Game TechnologyInteractive gaming machine and method with customized game screen presentation
US6350278 *Oct 18, 1999Feb 26, 2002Medtronic Ave, Inc.Apparatus and methods for placement and repositioning of intraluminal prostheses
US6355061 *Mar 5, 1999Mar 12, 2002Endovascular Technologies, Inc.Method for deploying bifurcated graft using a multicapsule system
US6368344 *Dec 16, 1999Apr 9, 2002Advanced Cardiovascular Systems, Inc.Stent deployment system with reinforced inner member
US6368557 *Dec 30, 1998Apr 9, 2002Cardiovention, Inc.Integrated blood oxygenator and pump system having means for reducing manifold flooding
US6375670 *Aug 25, 2000Apr 23, 2002Prodesco, Inc.Intraluminal filter
US6375676 *May 17, 1999Apr 23, 2002Advanced Cardiovascular Systems, Inc.Self-expanding stent with enhanced delivery precision and stent delivery system
US6379618 *Dec 30, 1998Apr 30, 2002Cardiovention, Inc.Integrated blood oxygenator and pump system having means for reducing microbubble generation
US6380457 *Oct 27, 1997Apr 30, 2002Boston Scientific Scimed, Inc.Apparatus for deploying body implantable stents
US6503450 *Dec 30, 1999Jan 7, 2003Cardiovention, Inc.Integrated blood oxygenator and pump system
US6514261 *Sep 30, 1999Feb 4, 2003Impra, Inc.Delivery mechanism for implantable stent
US6524299 *Apr 9, 1997Feb 25, 2003Target Therapeutics, Inc.Flow-directed catheter
US6527769 *Feb 25, 2002Mar 4, 2003Atrionix, Inc.Tissue ablation system and method for forming long linear lesion
US6540778 *Apr 2, 2001Apr 1, 2003Endovascular Technologies, Inc.Multicapsule intraluminal grafting system and method
US6547779 *Jun 9, 1999Apr 15, 2003Endovasix, Inc.Flexible flow apparatus and method for the disruption of occlusions
US6673089 *Aug 11, 2000Jan 6, 2004Mindguard Ltd.Implantable stroke treating device
US6682557 *Dec 18, 2001Jan 27, 2004Endovascular Technologies, Inc.Bifurcated multicapsule intraluminal grafting system and method
US6685735 *Jun 22, 2000Feb 3, 2004Endovascular Technologies, Inc.Syent/graft deployment catheter with a stent/graft attachment mechanism
US6709454 *Jan 31, 2000Mar 23, 2004Advanced Cardiovascular Systems, Inc.Self-expanding stent with enhanced delivery precision and stent delivery system
US6712834 *Dec 14, 2000Mar 30, 2004Mindguard Ltd.Implantable blood filtering device
US6726700 *Aug 21, 2000Apr 27, 2004Counter Clockwise, Inc.Manipulatable delivery catheter for occlusive devices
US6849084 *Dec 31, 2002Feb 1, 2005Intek Technology L.L.C.Stent delivery system
US6858034 *May 18, 2000Feb 22, 2005Scimed Life Systems, Inc.Stent delivery system for prevention of kinking, and method of loading and using same
US6860893 *Oct 9, 2001Mar 1, 2005Boston Scientific Scimed, Inc.Stable coil designs
US6860898 *Jul 31, 2001Mar 1, 2005Advanced Cardiovascular Systems, Inc.Self-expanding stent with enhanced delivery precision and stent delivery system
US6860901 *Jul 2, 2002Mar 1, 2005Endovascular Technologies, Inc.Intraluminal grafting system
US6866680 *Sep 10, 2001Mar 15, 2005Mindguard Ltd.Implantable stroke preventing device
US6994721 *Oct 21, 2002Feb 7, 2006Israel Henry MStent assembly
US7001422 *Feb 12, 2003Feb 21, 2006Cordis Neurovascular, IncExpandable stent and delivery system
US7004964 *Feb 22, 2002Feb 28, 2006Scimed Life Systems, Inc.Apparatus and method for deployment of an endoluminal device
US7011675 *Apr 30, 2001Mar 14, 2006Boston Scientific Scimed, Inc.Endoscopic stent delivery system and method
US7166125 *Oct 10, 2000Jan 23, 2007Endovascular Technologies, Inc.Intraluminal grafting system
US7169170 *Feb 22, 2002Jan 30, 2007Cordis CorporationSelf-expanding stent delivery system
US7169172 *Nov 1, 2002Jan 30, 2007Counter Clockwise, Inc.Method and apparatus for caged stent delivery
US7172617 *Jan 14, 2002Feb 6, 2007Boston Scientific Scimed, Inc.Stent delivery system
US7195639 *Jan 23, 2004Mar 27, 2007Endovascular Technologies, Inc.Bifurcated multicapsule intraluminal grafting system and method
US7195648 *Apr 29, 2003Mar 27, 2007Cordis Neurovascular, Inc.Intravascular stent device
US7201769 *Sep 20, 2004Apr 10, 2007Cordis Neurovascular, Inc.Expandable stent and delivery system
US7320702 *Jun 8, 2005Jan 22, 2008Xtent, Inc.Apparatus and methods for deployment of multiple custom-length prostheses (III)
US7331973 *Sep 30, 2002Feb 19, 2008Avdanced Cardiovascular Systems, Inc.Guide wire with embolic filtering attachment
US7331976 *Mar 12, 2004Feb 19, 2008Rex Medical, L.P.Distal protection device
US7331985 *Dec 23, 2005Feb 19, 2008Scimed Life Systems, Inc.Apparatus and method for deployment of an endoluminal device
US7338518 *Aug 10, 2005Mar 4, 2008Boston Scientific Santa Rosa Corp.Delivery system and method for expandable intracorporeal device
US7473271 *Apr 11, 2003Jan 6, 2009Boston Scientific Scimed, Inc.Stent delivery system with securement and deployment accuracy
US7491224 *Dec 29, 2003Feb 17, 2009Advanced Cardiovascular Systems, Inc.Radiopaque catheter tip for enhanced delivery precision of a stent using a guidewire
US20030069522 *Aug 5, 2002Apr 10, 2003Jacobsen Stephen J.Slotted medical device
US20040044395 *Sep 3, 2002Mar 4, 2004Scimed Life Systems, Inc.Elephant trunk thoracic endograft and delivery system
US20040073300 *Jul 30, 2003Apr 15, 2004Chouinard Paul F.Process for manufacturing a braided bifurcated stent
US20050090888 *Oct 28, 2003Apr 28, 2005Hines Richard A.Pleated stent assembly
US20060089703 *Dec 12, 2005Apr 27, 2006Angeli EscamillaExpandable stent and delivery system
US20070021816 *Jul 20, 2006Jan 25, 2007The Research Foundation Of State University Of New YorkStent vascular intervention device and methods for treating aneurysms
US20070043419 *Mar 23, 2004Feb 22, 2007Cardiomind, Inc.Implant delivery technologies
US20070060994 *Sep 12, 2005Mar 15, 2007Gobran Riad HBlood flow diverters for the treatment of intracranial aneurysms
US20080039933 *Oct 16, 2007Feb 14, 2008Surpass Medical Ltd.Implantable intraluminal device and method of using same in treating aneurysms
US20080082154 *Sep 28, 2007Apr 3, 2008Cook IncorporatedStent Graft Delivery System for Accurate Deployment
US20090024202 *Oct 1, 2008Jan 22, 2009Vipul Bhupendra DaveCea system and method for delivering a self-expanding stent
US20090024205 *Nov 30, 2007Jan 22, 2009Bay Street MedicalRadially Expandable Stent
US20090030496 *Jul 23, 2008Jan 29, 2009Ralf KaufmannInsertion system for stents, comprising tension-compression kinematics
US20090030497 *Jul 24, 2008Jan 29, 2009Metcalf Justin MRetention Wire For Self-Expanding Stent
US20090105802 *Dec 17, 2008Apr 23, 2009Boston Scientific Scimed, Inc.Stent delivery catheter
US20090105803 *Dec 19, 2008Apr 23, 2009Boston Scientific Scimed, Inc.Stent grip and systems for use therewith
Referenced by
Citing PatentFiling datePublication dateApplicantTitle
US7942925May 17, 2011Surpass Medical Ltd.Implantable intraluminal device and method of using same in treating aneurysms
US8142456Apr 21, 2009Mar 27, 2012Nfocus Neuromedical, Inc.Braid-ball embolic devices
US8147534May 25, 2005Apr 3, 2012Tyco Healthcare Group LpSystem and method for delivering and deploying an occluding device within a vessel
US8187315Dec 8, 2006May 29, 2012Cardica, Inc.Partial stent for treatment of a vascular aneurysm
US8236042Apr 8, 2009Aug 7, 2012Tyco Healthcare Group LpSystem and method for delivering and deploying an occluding device within a vessel
US8257421Apr 6, 2009Sep 4, 2012Tyco Healthcare Group LpSystem and method for delivering and deploying an occluding device within a vessel
US8267985Sep 18, 2012Tyco Healthcare Group LpSystem and method for delivering and deploying an occluding device within a vessel
US8273101Sep 25, 2012Tyco Healthcare Group LpSystem and method for delivering and deploying an occluding device within a vessel
US8382825Feb 26, 2013Covidien LpFlexible vascular occluding device
US8394119Mar 12, 2013Covidien LpStents having radiopaque mesh
US8398701May 25, 2005Mar 19, 2013Covidien LpFlexible vascular occluding device
US8419787Feb 21, 2010Apr 16, 2013Surpass Medical LtdImplantable intraluminal device and method of using same in treating aneurysms
US8617234May 24, 2006Dec 31, 2013Covidien LpFlexible vascular occluding device
US8623067Apr 17, 2009Jan 7, 2014Covidien LpMethods and apparatus for luminal stenting
US8628564Apr 17, 2009Jan 14, 2014Covidien LpMethods and apparatus for luminal stenting
US8636760Aug 28, 2012Jan 28, 2014Covidien LpSystem and method for delivering and deploying an occluding device within a vessel
US8641748Jan 19, 2006Feb 4, 2014Bay Street Medical, Inc.Guidewire loaded stent for delivery through a catheter
US8696701Sep 28, 2012Apr 15, 2014Covidien LpBraid-ball embolic devices
US8696728Aug 31, 2007Apr 15, 2014Bay Street Medical, Inc.Guidewire loaded stent for delivery through a catheter
US8715316Aug 29, 2013May 6, 2014Insera Therapeutics, Inc.Offset vascular treatment devices
US8715317Dec 2, 2013May 6, 2014Insera Therapeutics, Inc.Flow diverting devices
US8721676Aug 28, 2013May 13, 2014Insera Therapeutics, Inc.Slotted vascular treatment devices
US8721677Dec 18, 2013May 13, 2014Insera Therapeutics, Inc.Variably-shaped vascular devices
US8728116Aug 29, 2013May 20, 2014Insera Therapeutics, Inc.Slotted catheters
US8728117Dec 2, 2013May 20, 2014Insera Therapeutics, Inc.Flow disrupting devices
US8733618Aug 28, 2013May 27, 2014Insera Therapeutics, Inc.Methods of coupling parts of vascular treatment systems
US8735777Aug 29, 2013May 27, 2014Insera Therapeutics, Inc.Heat treatment systems
US8747597Mar 15, 2011Jun 10, 2014Covidien LpMethods for making braid-ball occlusion devices
US8753371Nov 25, 2013Jun 17, 2014Insera Therapeutics, Inc.Woven vascular treatment systems
US8783151Aug 28, 2013Jul 22, 2014Insera Therapeutics, Inc.Methods of manufacturing vascular treatment devices
US8784446Mar 25, 2014Jul 22, 2014Insera Therapeutics, Inc.Circumferentially offset variable porosity devices
US8789452Aug 28, 2013Jul 29, 2014Insera Therapeutics, Inc.Methods of manufacturing woven vascular treatment devices
US8790365Mar 25, 2014Jul 29, 2014Insera Therapeutics, Inc.Fistula flow disruptor methods
US8795330Mar 25, 2014Aug 5, 2014Insera Therapeutics, Inc.Fistula flow disruptors
US8803030Mar 25, 2014Aug 12, 2014Insera Therapeutics, Inc.Devices for slag removal
US8813625Jan 29, 2014Aug 26, 2014Insera Therapeutics, Inc.Methods of manufacturing variable porosity flow diverting devices
US8816247Mar 25, 2014Aug 26, 2014Insera Therapeutics, Inc.Methods for modifying hypotubes
US8828045Mar 25, 2014Sep 9, 2014Insera Therapeutics, Inc.Balloon catheters
US8845678Aug 28, 2013Sep 30, 2014Insera Therapeutics Inc.Two-way shape memory vascular treatment methods
US8845679Jan 29, 2014Sep 30, 2014Insera Therapeutics, Inc.Variable porosity flow diverting devices
US8852227Aug 29, 2013Oct 7, 2014Insera Therapeutics, Inc.Woven radiopaque patterns
US8859934Mar 25, 2014Oct 14, 2014Insera Therapeutics, Inc.Methods for slag removal
US8863631Jan 29, 2014Oct 21, 2014Insera Therapeutics, Inc.Methods of manufacturing flow diverting devices
US8866049Mar 25, 2014Oct 21, 2014Insera Therapeutics, Inc.Methods of selectively heat treating tubular devices
US8869670Jan 29, 2014Oct 28, 2014Insera Therapeutics, Inc.Methods of manufacturing variable porosity devices
US8870901Aug 28, 2013Oct 28, 2014Insera Therapeutics, Inc.Two-way shape memory vascular treatment systems
US8870910Dec 2, 2013Oct 28, 2014Insera Therapeutics, Inc.Methods of decoupling joints
US8872068Mar 25, 2014Oct 28, 2014Insera Therapeutics, Inc.Devices for modifying hypotubes
US8876876Jun 6, 2008Nov 4, 2014Back Bay Medical Inc.Prosthesis and delivery system
US8882797Apr 22, 2014Nov 11, 2014Insera Therapeutics, Inc.Methods of embolic filtering
US8895891Jan 29, 2014Nov 25, 2014Insera Therapeutics, Inc.Methods of cutting tubular devices
US8904914Apr 22, 2014Dec 9, 2014Insera Therapeutics, Inc.Methods of using non-cylindrical mandrels
US8910555Apr 22, 2014Dec 16, 2014Insera Therapeutics, Inc.Non-cylindrical mandrels
US8926681Jan 28, 2011Jan 6, 2015Covidien LpVascular remodeling device
US8932320Apr 16, 2014Jan 13, 2015Insera Therapeutics, Inc.Methods of aspirating thrombi
US8932321Apr 24, 2014Jan 13, 2015Insera Therapeutics, Inc.Aspiration systems
US9034007Sep 21, 2007May 19, 2015Insera Therapeutics, Inc.Distal embolic protection devices with a variable thickness microguidewire and methods for their use
US9039726Oct 25, 2010May 26, 2015Covidien LpFilamentary devices for treatment of vascular defects
US9050205Jul 20, 2012Jun 9, 2015Covidien LpMethods and apparatus for luminal stenting
US9060886Sep 28, 2012Jun 23, 2015Covidien LpVascular remodeling device
US9089332Mar 23, 2012Jul 28, 2015Covidien LpVascular remodeling device
US9095342Nov 9, 2010Aug 4, 2015Covidien LpBraid ball embolic device features
US9095343Feb 29, 2012Aug 4, 2015Covidien LpSystem and method for delivering and deploying an occluding device within a vessel
US9114001Mar 14, 2013Aug 25, 2015Covidien LpSystems for attaining a predetermined porosity of a vascular device
US9114038Aug 31, 2007Aug 25, 2015Back Bay Medical Inc.Method of delivering a stent
US9125659Mar 18, 2013Sep 8, 2015Covidien LpFlexible vascular occluding device
US9144508Nov 30, 2007Sep 29, 2015Back Bay Medical Inc.Radially expandable stent
US9155647Jul 18, 2012Oct 13, 2015Covidien LpMethods and apparatus for luminal stenting
US9157174Mar 14, 2013Oct 13, 2015Covidien LpVascular device for aneurysm treatment and providing blood flow into a perforator vessel
US9179918Jul 21, 2009Nov 10, 2015Covidien LpVascular remodeling device
US9179931Aug 28, 2013Nov 10, 2015Insera Therapeutics, Inc.Shape-set textile structure based mechanical thrombectomy systems
US9179995Aug 28, 2013Nov 10, 2015Insera Therapeutics, Inc.Methods of manufacturing slotted vascular treatment devices
US9198666Jul 16, 2012Dec 1, 2015Covidien LpSystem and method for delivering and deploying an occluding device within a vessel
US9204983Aug 28, 2012Dec 8, 2015Covidien LpSystem and method for delivering and deploying an occluding device within a vessel
US9211202Oct 24, 2008Dec 15, 2015Wisconsin Alumni Research FoundationApparatus and method for treating an aneurysm
US9295568Sep 17, 2013Mar 29, 2016Covidien LpMethods and apparatus for luminal stenting
US9295571Mar 12, 2013Mar 29, 2016Covidien LpMethods and apparatus for luminal stenting
US9301831Mar 14, 2013Apr 5, 2016Covidien LpMethods for attaining a predetermined porosity of a vascular device
US9314248Nov 6, 2012Apr 19, 2016Covidien LpMulti-pivot thrombectomy device
US9314324Sep 8, 2015Apr 19, 2016Insera Therapeutics, Inc.Vascular treatment devices and methods
US9320590Mar 11, 2013Apr 26, 2016Covidien LpStents having radiopaque mesh
US20070198076 *Feb 7, 2007Aug 23, 2007Stephen HebertSystem for delivering a stent
US20070299501 *Aug 31, 2007Dec 27, 2007Counter Clockwise, Inc.Guidewire loaded stent for delivery through a catheter
US20070299502 *Aug 31, 2007Dec 27, 2007Counter Clockwise, Inc.Guidewire loaded stent for delivery through a catheter
US20080221600 *Aug 17, 2007Sep 11, 2008Dieck Martin SIsolation devices for the treatment of aneurysms
US20090123914 *Sep 23, 2005May 14, 2009Ingeneus Inc.Genomic Assay
US20090306760 *Jun 6, 2008Dec 10, 2009Bay Street MedicalProsthesis and delivery system
US20090306761 *Dec 10, 2009Bay Street MedicalProsthesis and delivery system
US20100106180 *Oct 24, 2008Apr 29, 2010Strother Charles MApparatus and method for treating an aneurysm
US20110040372 *Feb 13, 2009Feb 17, 2011Hansen Palle MCoated Endoluminal Implant
EP2419048A1 *Apr 14, 2010Feb 22, 2012Tyco Healthcare Group, LPVascular stenting for aneurysms
EP2419048A4 *Apr 14, 2010Apr 9, 2014Covidien LpVascular stenting for aneurysms
WO2009105176A3 *Feb 13, 2009Dec 3, 2009William Cook Europe ApsCoated endoluminal implant
WO2012154782A1May 9, 2012Nov 15, 2012Tyco Healthcare Group LpVascular remodeling device
WO2013162817A1Mar 28, 2013Oct 31, 2013Covidien LpDelivery system with hooks for resheathability
Classifications
U.S. Classification623/1.51
International ClassificationA61F2/82, A61F2/90, A61B17/12
Cooperative ClassificationA61B2017/1205, A61F2230/0091, A61F2/90, A61F2230/0078, A61F2002/823, A61F2230/0095, A61B17/12022, A61B17/12118, A61B17/12113
European ClassificationA61B17/12P5B1S, A61F2/90, A61B17/12P
Legal Events
DateCodeEventDescription
May 26, 2006ASAssignment
Owner name: CHESTNUT MEDICAL TECHNOLOGIES, INC., CALIFORNIA
Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:GARCIA, ADRIAN;YE, TING TINA;TRAN, QUANG Q;AND OTHERS;REEL/FRAME:017684/0120
Effective date: 20060523
Jan 24, 2013ASAssignment
Owner name: TYCO HEALTHCARE GROUP LP, MASSACHUSETTS
Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:EV3 LLC;REEL/FRAME:029690/0429
Effective date: 20101223
Owner name: EV3 INC., MINNESOTA
Free format text: MERGER;ASSIGNOR:CHESTNUT MEDICAL TECHNOLOGIES, INC.;REEL/FRAME:029690/0402
Effective date: 20101220
Owner name: EV3 LLC, MINNESOTA
Free format text: MERGER;ASSIGNOR:EV3 INC.;REEL/FRAME:029693/0429
Effective date: 20101222
Owner name: COVIDIEN LP, MASSACHUSETTS
Free format text: CHANGE OF NAME;ASSIGNOR:TYCO HEALTHCARE GROUP LP;REEL/FRAME:029693/0435
Effective date: 20120928